Skip to main content

New Products: Jan 19, 2010

Premium

CLC Bio has released CLC Genomics Server 2.0, an enterprise platform for next-generation sequencing data analysis. The new version has a number of additions, including parallelization of jobs on multiple computers, integration of third-party command-line tools and algorithms through a graphical user interface, support for file sharing and data management, and additional high-throughput sequencing analyses including digital gene expression, de novo assembly, reference assembly, SNP & DIP detection, and ChIP-seq analysis.

The platform comprises desktop applications, server software, and centralized data sharing and data management. It also includes an application programming interface for integration and custom plug-in development.


Nvidia launched the Tesla Bio Workbench, a suite of bioscience and bioinformatics applications for molecular dynamics and quantum chemistry-based research. The workbench has been designed to run complex simulations in fields such as DNA sequencing and drug discovery on a standard PC. The company said the workbench is 10 to 20 times faster than other simulations.

Currently available bioscience applications include AMBER, GROMACS, LAMMPS, NAMD, TeraChem and VMD, while bioinformatics applications including CUDA-SW++ (Smith-Waterman), GPU-HMMER, and MUMmerGPU will be available next month.

The workbench also includes a community site where users can download applications, read academic papers, and join discussion forums.


Epicentre Biotechnologies released Nextera kits designed to prepare libraries for Illumina sequencers. The announcement follows on a previous launch of Nextera kits that were designed for Roche 454 GS FLX and Titanium sequencers. The kits enable library preparation from 50 ng of DNA in under two hours and they use Epicentre's transposon-based technology to randomly fragment the template DNA and tag the ends in a single-tube reaction.

The Scan

WHO OKs Emergency Use of Sinopharm Vaccine

The World Health Organization has granted emergency approval for Sinopharm's SARS-CoV-2 vaccine, the Guardian reports.

Scientific Integrity Panel to Meet

According to the Associated Press, a new US scientific integrity panel is to meet later this week.

Trying in the Eye

NPR reports that a study of Editas Medicine's CRISPR therapy for Leber congenital amaurosis has begun.

PLOS Papers on Cerebellum Epigenetics, Copy Number Signature Tool, Acute Lung Injury Networks

In PLOS this week: epigenetics analysis of brain tissue, bioinformatics tool to find copy number signatures in cancer, and more.